Clinical Trials Directory

Trials / Completed

CompletedNCT00468962

The Effct of Chitooligosaccharide on Immune Function in Healthy Adults

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
Sponsor
Eulji University Hospital · Academic / Other
Sex
All
Age
20 Years – 50 Years
Healthy volunteers

Summary

Functional properties of chitooligosaccharides have been studied for antitumor activity, immunostimulating effects, antimicrobial activity, free radical scavening activity, adn angiotensin I converting enzyme inhibitory activity. Recent in vitro, and in vivo toxicity and absorbability studies have demonstrated that chitooligosaccharides have high absorbability and are essentially non-toxic. In the present study, we prepared a chitooligosaccharide with high absorbability and evaluated its effects on activation of immune function and cardiovascular funciton(lipid, atrial stiffness, etc) in healthy adults. This study was a 8-week, randomized, double-blind clinical trial. The 30 volunteers were divided into a control group(n=10), half dose chitooligosaccaride(FACOSTM) intake group(n=10), and full dose FACOS intake group(n=10). Peripheral blood mononuclear cells(PBMCs) were isolated and cultured in 12 well plate for 48 hours. Cytokine production by PBMCs pre- and postintervention were measured simultaneously after stimulation with lipopolysaccaride.

Conditions

Interventions

TypeNameDescription
DRUGFACOS (functional food)

Timeline

First posted
2007-05-03
Last updated
2007-05-03

Source: ClinicalTrials.gov record NCT00468962. Inclusion in this directory is not an endorsement.